Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
713,634,913
-
Total 13F shares
-
508,587,107
-
Share change
-
+6,247,427
-
Total reported value
-
$11,032,890,046
-
Put/Call ratio
-
33%
-
Price per share
-
$21.70
-
Number of holders
-
394
-
Value change
-
+$193,924,197
-
Number of buys
-
242
-
Number of sells
-
134
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2025
As of 31 Dec 2025,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
394 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
508,587,107 shares.
The largest 10 holders included
FMR LLC, MORGAN STANLEY, VANGUARD GROUP INC, BlackRock, Inc., QVT Financial LP, UBS Group AG, STATE STREET CORP, SB INVESTMENT ADVISERS (UK) LTD, GOLDMAN SACHS GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
394
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.